应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
08058 罗欣药业
退市 06-05 15:59:45
16.960
-0.020
-0.12%
最高
16.980
最低
16.940
成交量
72.00万
今开
16.940
昨收
16.980
日振幅
0.24%
总市值
103.39亿
流通市值
27.91亿
总股本
6.10亿
成交额
1,221万
换手率
0.44%
流通股本
1.65亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
罗欣药业:截至目前股东总户数为36,524
证券之星 · 07-03
罗欣药业:截至目前股东总户数为36,524
化学制药行业2日主力净流出17.04亿元,罗欣药业、上海谊众居前
金融界 · 07-02
化学制药行业2日主力净流出17.04亿元,罗欣药业、上海谊众居前
罗欣药业(002793)股东山东罗欣控股有限公司质押3602万股,占总股本3.31%
证券之星 · 06-30
罗欣药业(002793)股东山东罗欣控股有限公司质押3602万股,占总股本3.31%
罗欣药业最新公告:股东拟减持不超过0.97%公司股份
证券之星 · 06-12
罗欣药业最新公告:股东拟减持不超过0.97%公司股份
异动快报:罗欣药业(002793)6月9日9点46分触及涨停板
证券之星 · 06-09
异动快报:罗欣药业(002793)6月9日9点46分触及涨停板
罗欣药业:截止至 2025年5月20日,公司股东总户数为30,732
证券之星 · 06-04
罗欣药业:截止至 2025年5月20日,公司股东总户数为30,732
每周股票复盘:罗欣药业(002793)布洛芬注射液获批视同通过一致性评价
证券之星 · 05-31
每周股票复盘:罗欣药业(002793)布洛芬注射液获批视同通过一致性评价
罗欣药业:公司始终坚持依法履行信息披露义务并积极披露重要信息
证券之星 · 05-29
罗欣药业:公司始终坚持依法履行信息披露义务并积极披露重要信息
罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书
智通财经 · 05-27
罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书
每周股票复盘:罗欣药业(002793)现898.71万元大宗交易
证券之星 · 05-24
每周股票复盘:罗欣药业(002793)现898.71万元大宗交易
5月23日罗欣药业现898.71万元大宗交易
证券之星 · 05-23
5月23日罗欣药业现898.71万元大宗交易
罗欣药业5月23日现1笔大宗交易 总成交金额898.71万元 溢价率为-0.90%
新浪证券-红岸工作室 · 05-23
罗欣药业5月23日现1笔大宗交易 总成交金额898.71万元 溢价率为-0.90%
罗欣药业:截止至2025年5月20日公司股东总户数为30732
证券之星 · 05-22
罗欣药业:截止至2025年5月20日公司股东总户数为30732
罗欣药业最新公告:合计持股5%以上股东终止协议转让公司部分股份
证券之星 · 05-16
罗欣药业最新公告:合计持股5%以上股东终止协议转让公司部分股份
罗欣药业:截止至 2025年5月9日,公司股东总户数为31,442
证券之星 · 05-13
罗欣药业:截止至 2025年5月9日,公司股东总户数为31,442
罗欣药业:截止至 2025年4月30日,公司股东总户数为33,475
证券之星 · 05-07
罗欣药业:截止至 2025年4月30日,公司股东总户数为33,475
罗欣药业:截止至 2025年4月18日,公司股东总户数为32,747
证券之星 · 04-25
罗欣药业:截止至 2025年4月18日,公司股东总户数为32,747
罗欣药业:公司2025年一季度实现扭亏为盈
证券之星 · 04-24
罗欣药业:公司2025年一季度实现扭亏为盈
4月24日罗欣药业(002793)涨停分析:蒙脱石散板块、业绩扭亏驱动
证券之星 · 04-24
4月24日罗欣药业(002793)涨停分析:蒙脱石散板块、业绩扭亏驱动
异动快报:罗欣药业(002793)4月24日10点17分触及涨停板
证券之星 · 04-24
异动快报:罗欣药业(002793)4月24日10点17分触及涨停板
加载更多
公司概况
公司名称:
罗欣药业
所属市场:
SEHK
上市日期:
--
主营业务:
山东罗欣药业股份有限公司是原山东罗欣制药厂改制重组,由临沂罗欣医药有限公司控股,联合沈阳药科大学等共11家发起人共同发起设立的股份有限公司,是严格按照现代企业制度和国家GMP要求组建的制药企业,是国家级高新技术企业。公司经营范围:中西药品、医药原料药的研制、开发、生产、销售。公司建有冻干粉针剂、粉针剂、水针剂、固体制剂、头孢菌素类原料药、口服头孢系列产品等三十多条生产线,已全部通过国家GMP认证。
发行价格:
--
{"stockData":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"罗欣药业","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"floatShares":164560000,"shares":609600000,"eps":0.6795868056645838,"marketStatus":"退市","change":-0.02,"latestTime":"06-05 15:59:45","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752111000000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1752024600000,1752033600000],[1752037200000,1752048000000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08058","defaultTab":"news","newsList":[{"id":"2548802500","title":"罗欣药业:截至目前股东总户数为36,524","url":"https://stock-news.laohu8.com/highlight/detail?id=2548802500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548802500?lang=zh_cn&edition=full","pubTime":"2025-07-03 20:52","pubTimestamp":1751547153,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问:截至到2025年6月10日贵公司的股东人数是多少?罗欣药业回复:尊敬的投资者,您好!截至目前,公司最新一期(2025年6月30日)股东总户数为36,524。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300036301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0201","BK0132","BK0239","002793"],"gpt_icon":0},{"id":"2548865828","title":"化学制药行业2日主力净流出17.04亿元,罗欣药业、上海谊众居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2548865828","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548865828?lang=zh_cn&edition=full","pubTime":"2025-07-02 15:46","pubTimestamp":1751442364,"startTime":"0","endTime":"0","summary":"7月2日,化学制药行业下跌0.82%,今日主力资金流出17.04亿元,成分股32只上涨,64只下跌。主力资金净流出居前的分别为罗欣药业、上海谊众、恩华药业、万邦德、健友股份。序号代码名称最新价涨跌幅主力净流入主力净占比1603538美诺华23.1810.011.43亿元11.88%2002365永安药业28.260.218400.99万元4.58%3603367辰欣药业14.723.373101.91万元12.21%4002900哈三联15.65.263011.73万元4.56%5603811诚意药业10.4510.02931.27万元25.53%6688166博瑞医药52.89-2.381995.23万元9.5%7000915华特达因33.22-4.071991.85万元6.24%8603520司太立10.041.211289.77万元12.16%9000953河化股份7.415.411169.23万元2.34%10000813德展健康3.270.621052.17万元11.1%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/02154651438387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0132","01477","BK0201","688091","BK0239","08058","002793","BK1574","BK1191","BK0001"],"gpt_icon":0},{"id":"2548301166","title":"罗欣药业(002793)股东山东罗欣控股有限公司质押3602万股,占总股本3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548301166","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548301166?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:24","pubTimestamp":1751300677,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业7月1日公开信息显示,股东山东罗欣控股有限公司向浙江炳炳典当有限公司合计质押3602.0万股,占总股本3.31%。质押详情见下表:截止本公告日,股东山东罗欣控股有限公司已累计质押股份1.55亿股,占其持股总数的65.4%。罗欣药业主营业务:医药产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100001033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","BK0239","002793","BK0132","BK0201"],"gpt_icon":0},{"id":"2542461519","title":"罗欣药业最新公告:股东拟减持不超过0.97%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2542461519","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542461519?lang=zh_cn&edition=full","pubTime":"2025-06-12 20:01","pubTimestamp":1749729663,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称,公司持股5%以上股东方秀宝及其一致行动人方东晖、温岭市大任企业管理有限公司合计持有公司股份131,620,846股,占剔除回购专用账户后的总股本比例12.19%。大任管理拟通过集中竞价交易或大宗交易方式合计减持公司股份数量不超过10,442,080股,占公司总股本比例0.96%,占剔除回购专用账户后的总股本比例0.97%。减持期间为公告披露日起15个交易日后的三个月内。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061200031602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","08058","BK0239","002793","BK0201"],"gpt_icon":0},{"id":"2542545873","title":"异动快报:罗欣药业(002793)6月9日9点46分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2542545873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542545873?lang=zh_cn&edition=full","pubTime":"2025-06-09 09:50","pubTimestamp":1749433844,"startTime":"0","endTime":"0","summary":"证券之星6月9日盘中消息,9点46分罗欣药业触及涨停板。目前价格5.26,上涨10.04%。其所属行业化学制药目前上涨。领涨股为海辰药业。该股为化学原料药,创新药,医药概念热股,当日化学原料药概念上涨2.53%,创新药概念上涨2.37%,医药概念上涨2.04%。6月6日的资金流向数据方面,主力资金净流入401.49万元,占总成交额2.6%,游资资金净流入319.06万元,占总成交额2.06%,散户资金净流出720.55万元,占总成交额4.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900003536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0201","BK0239","BK0132","002793"],"gpt_icon":0},{"id":"2540406618","title":"罗欣药业:截止至 2025年5月20日,公司股东总户数为30,732","url":"https://stock-news.laohu8.com/highlight/detail?id=2540406618","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540406618?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:57","pubTimestamp":1749041845,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月20日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年5月20日,公司股东总户数为30,732。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400036511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0001","BK0132","08058","BK0239","BK0201"],"gpt_icon":0},{"id":"2539209815","title":"每周股票复盘:罗欣药业(002793)布洛芬注射液获批视同通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2539209815","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539209815?lang=zh_cn&edition=full","pubTime":"2025-05-31 08:29","pubTimestamp":1748651383,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,罗欣药业报收于4.61元,较上周的4.42元上涨4.3%。近日,罗欣药业集团股份有限公司下属子公司山东罗欣药业集团股份有限公司收到国家药品监督管理局核准签发的布洛芬注射用浓溶液《药品注册证书》。审批结论为符合药品注册的有关要求,批准注册,发给药品注册证书。公司布洛芬注射用浓溶液获得药品注册证书,视同通过仿制药质量和疗效一致性评价,适用于成人发热的退热治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100008331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","BK0201","BK0239","002793","BK0132"],"gpt_icon":0},{"id":"2539263871","title":"罗欣药业:公司始终坚持依法履行信息披露义务并积极披露重要信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2539263871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539263871?lang=zh_cn&edition=full","pubTime":"2025-05-29 20:55","pubTimestamp":1748523331,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业05月28日在投资者关系平台上答复投资者关心的问题。公司始终坚持按照相关法律法规、规范性文件及内部制度的要求,依法履行信息披露义务,并积极结合医药行业特点,有针对性地披露公司产品研发进展、获批上市等有助于投资者了解公司的重要信息。公司披露的定期报告涵盖了产业信息,具体可通过巨潮资讯网查阅公司相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900035421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0201","08058","BK0239","BK0001"],"gpt_icon":0},{"id":"2538572844","title":"罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2538572844","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538572844?lang=zh_cn&edition=full","pubTime":"2025-05-27 18:12","pubTimestamp":1748340732,"startTime":"0","endTime":"0","summary":"智通财经APP讯,罗欣药业(002793.SZ)公告,公司下属子公司山东罗欣药业集团股份有限公司收到国家药品监督管理局核准签发的布洛芬注射用浓溶液《药品注册证书》。公告显示,布洛芬属非甾体类抗炎药,具有镇痛、抗炎、解热作用,是一种有效的前列腺素(PG)合成抑制剂。病原体及其毒素侵袭人体后,产生与释放内热原,使中枢合成并释放PG增多,PG是一类具有高度生物活性的物质,参与机体发热、疼痛、炎症、血栓形成、过敏等多种生理、病理过程,非甾体类抗炎药能抑制合成前列腺素所必须的环加氧酶(COX)的活性,从而阻止PG的合成来发挥其药理作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","BK0132","BK0201","002793","BK0239","BK0001"],"gpt_icon":0},{"id":"2537919539","title":"每周股票复盘:罗欣药业(002793)现898.71万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2537919539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537919539?lang=zh_cn&edition=full","pubTime":"2025-05-24 19:03","pubTimestamp":1748084596,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,罗欣药业(002793)报收于4.42元,较上周的4.42元上涨0.0%。本周,罗欣药业5月23日盘中最高价报4.66元。5月19日盘中最低价报4.32元。罗欣药业当前最新总市值48.07亿元,在化学制药板块市值排名89/150,在两市A股市值排名2946/5148。本周关注点交易信息汇总: 5月23日罗欣药业现898.71万元大宗交易交易信息汇总5月23日罗欣药业发生了898.71万元的大宗交易。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400013429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","08058","BK0001","BK0239","002793","BK0132"],"gpt_icon":0},{"id":"2537189483","title":"5月23日罗欣药业现898.71万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2537189483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537189483?lang=zh_cn&edition=full","pubTime":"2025-05-23 17:13","pubTimestamp":1747991580,"startTime":"0","endTime":"0","summary":"证券之星消息,5月23日罗欣药业发生大宗交易,交易数据如下:大宗交易成交价格4.38元,相对当日收盘价折价0.9%,成交205.18万股,成交金额898.71万元,买方营业部为中信证券股份有限公司北京总部证券营业部,卖方营业部为中信证券(山东)有限责任公司临沂金雀山路证券营业部。近三个月该股共发生1笔大宗交易,合计成交2.05万手,折价成交1笔。截至2025年5月23日收盘,罗欣药业报收于4.42元,上涨0.91%,换手率2.84%,成交量30.87万手,成交额1.39亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300026294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","08058","BK0239","BK0001","BK0201","002793"],"gpt_icon":0},{"id":"2537181189","title":"罗欣药业5月23日现1笔大宗交易 总成交金额898.71万元 溢价率为-0.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537181189","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537181189?lang=zh_cn&edition=full","pubTime":"2025-05-23 17:00","pubTimestamp":1747990800,"startTime":"0","endTime":"0","summary":" 5月23日,罗欣药业(维权)收涨0.91%,收盘价为4.42元,发生1笔大宗交易,合计成交量205.18万股,成交金额898.71万元。 进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为898.71万元。该股近5个交易日累计上涨0.00%,主力资金合计净流出2333.19万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-05-23/doc-inexpvsa6078331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0201","08058","BK0001","BK0239","002793","BK0132"],"gpt_icon":0},{"id":"2537924949","title":"罗欣药业:截止至2025年5月20日公司股东总户数为30732","url":"https://stock-news.laohu8.com/highlight/detail?id=2537924949","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537924949?lang=zh_cn&edition=full","pubTime":"2025-05-22 20:53","pubTimestamp":1747918407,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月20日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年5月20日,公司股东总户数为30,732。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200035333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0001","BK0132","BK0239","08058"],"gpt_icon":0},{"id":"2535133393","title":"罗欣药业最新公告:合计持股5%以上股东终止协议转让公司部分股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2535133393","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535133393?lang=zh_cn&edition=full","pubTime":"2025-05-16 18:50","pubTimestamp":1747392642,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称,公司于近日收到合计持股5%以上股东成都得怡欣华股权投资合伙企业(有限合伙)、克拉玛依市得怡欣华股权投资有限合伙企业、克拉玛依得怡健康产业投资有限合伙企业、克拉玛依得盛健康产业投资有限合伙企业的《关于协议转让终止事项的告知函》,因触发各方签署的《股份转让协议》第8.3条相关约定,本次股份转让终止。此次协议转让的股份尚未办理过户手续,未发生实质转让。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600031373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","08058","BK0239","002793","BK0001"],"gpt_icon":0},{"id":"2535748773","title":"罗欣药业:截止至 2025年5月9日,公司股东总户数为31,442","url":"https://stock-news.laohu8.com/highlight/detail?id=2535748773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535748773?lang=zh_cn&edition=full","pubTime":"2025-05-13 20:53","pubTimestamp":1747140789,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月9日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年5月9日,公司股东总户数为31,442。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300036220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0001","BK0132","BK0239","08058"],"gpt_icon":0},{"id":"2533980744","title":"罗欣药业:截止至 2025年4月30日,公司股东总户数为33,475","url":"https://stock-news.laohu8.com/highlight/detail?id=2533980744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533980744?lang=zh_cn&edition=full","pubTime":"2025-05-07 20:53","pubTimestamp":1746622401,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年4月30日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年4月30日,公司股东总户数为33,475。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700034554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002793","08058","BK0001","BK0201"],"gpt_icon":0},{"id":"2530055138","title":"罗欣药业:截止至 2025年4月18日,公司股东总户数为32,747","url":"https://stock-news.laohu8.com/highlight/detail?id=2530055138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530055138?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:51","pubTimestamp":1745585473,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年4月20日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年4月18日,公司股东总户数为32,747 。感谢您的关注!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0001","08058","BK0132","BK0201","002793"],"gpt_icon":0},{"id":"2529987358","title":"罗欣药业:公司2025年一季度实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2529987358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529987358?lang=zh_cn&edition=full","pubTime":"2025-04-24 20:52","pubTimestamp":1745499135,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业04月23日在投资者关系平台上答复投资者关心的问题。公司管理层通过商业模式升级、销售渠道整合、集团降本增效以及精细化运营等方式,多措并举争取扭亏。公司2025年一季度实现扭亏为盈,详情请见公司于2025年4月22日在巨潮资讯网披露的《罗欣药业:2025年一季度报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400038201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0132","002793","BK0239","BK0001","BK0201"],"gpt_icon":0},{"id":"2529462617","title":"4月24日罗欣药业(002793)涨停分析:蒙脱石散板块、业绩扭亏驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2529462617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529462617?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:30","pubTimestamp":1745479857,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业4月24日涨停收盘,收盘价4.72元。该股于10点17分涨停,未打开涨停,截止收盘封单资金为4890.66万元,占其流通市值0.95%。今日罗欣药业涨停的可能因素有:第一,蒙脱石散板块整体走强,市场对消化领域药品关注度提升;第二,公司2025年第一季度业绩预告显示净利润同比扭亏为盈,主要受益于创新药替戈拉生片市场份额显著提升;第三,公司在消化领域的持续技术布局及产品线拓展,增强了投资者对长期发展潜力的预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400020723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0132","002793","BK0239","BK0001","BK0201"],"gpt_icon":0},{"id":"2529615045","title":"异动快报:罗欣药业(002793)4月24日10点17分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2529615045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529615045?lang=zh_cn&edition=full","pubTime":"2025-04-24 10:20","pubTimestamp":1745461237,"startTime":"0","endTime":"0","summary":"证券之星4月24日盘中消息,10点17分罗欣药业触及涨停板。目前价格4.72,上涨10.02%。其所属行业化学制药目前上涨。领涨股为尔康制药。该股为化学原料药,幽门螺杆菌概念,医药概念热股,当日化学原料药概念上涨1.72%,幽门螺杆菌概念概念上涨1.26%,医药概念上涨1.03%。4月23日的资金流向数据方面,主力资金净流出2104.9万元,占总成交额15.44%,游资资金净流入667.64万元,占总成交额4.9%,散户资金净流入1437.26万元,占总成交额10.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400012252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","002793","BK0239","BK0201","BK0132"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luoxin.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":0.0149},{"period":"3month","weight":0.1916},{"period":"6month","weight":0.255},{"period":"1year","weight":0.378},{"period":"ytd","weight":0.2038}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东罗欣药业股份有限公司是原山东罗欣制药厂改制重组,由临沂罗欣医药有限公司控股,联合沈阳药科大学等共11家发起人共同发起设立的股份有限公司,是严格按照现代企业制度和国家GMP要求组建的制药企业,是国家级高新技术企业。公司经营范围:中西药品、医药原料药的研制、开发、生产、销售。公司建有冻干粉针剂、粉针剂、水针剂、固体制剂、头孢菌素类原料药、口服头孢系列产品等三十多条生产线,已全部通过国家GMP认证。","exchange":"SEHK","name":"罗欣药业","nameEN":"Shandong Luoxin Pharmaceutical Group"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(08058)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,08058,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(08058)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}